Moderna Booster Effective for at least 6 Months against Omicron

  • Thread starter Thread starter Tom.G
  • Start date Start date
Click For Summary
SUMMARY

The Moderna mRNA-1273 vaccine demonstrates effectiveness against the Omicron variant, with a booster dose significantly enhancing neutralization. Seven months post-second dose, only 55% of participants showed neutralization, with ID50 geometric mean titers 8.4 times lower than those for the D614G variant. Following a 50 μg booster, ID50 titers against Omicron increased 20.0 times, yet remained 2.9 times lower than D614G levels. This data confirms the necessity of booster doses for sustained protection against emerging variants.

PREREQUISITES
  • Understanding of mRNA vaccine technology
  • Familiarity with ID50 geometric mean titers
  • Knowledge of variant classifications (e.g., D614G, Omicron)
  • Awareness of Emergency Use Authorization protocols
NEXT STEPS
  • Research the long-term efficacy of mRNA vaccines against COVID-19 variants
  • Explore the impact of booster doses on immune response
  • Investigate the mechanisms of neutralization in mRNA vaccines
  • Learn about variant tracking and classification in virology
USEFUL FOR

Healthcare professionals, immunologists, vaccine researchers, and public health officials interested in COVID-19 vaccine efficacy and variant response.

Tom.G
Science Advisor
Gold Member
Messages
5,661
Reaction score
4,506

"Seven months after the second dose was administered (before the booster), neutralization of the omicron variant was detected in only 55% of the participants, and the ID50 geometric mean titers were 8.4 times lower than those against the D614G variant (Figure 1A). A booster dose of 50 μg of the mRNA-1273 vaccine, which is currently approved under Emergency Use Authorization for adults who are 18 years of age or older, was associated with ID50 geometric mean titers against the omicron variant that were 20.0 times higher than those assessed 1 month after the second vaccination; these titers were 2.9 times lower than those against the D614G variant."


Synopsis:
https://www.nejm.org/doi/full/10.1056/NEJMc2119912

Full article:
https://www.nejm.org/doi/full/10.1056/NEJMoa2116414?query=recirc_curatedRelated_article
 
  • Informative
Likes   Reactions: atyy
Biology news on Phys.org
It looks like the Moderna mRNA-1273 vaccine is able to protect against the omicron variant, but not as effectively as it does against the D614G variant. After 7 months, only 55% of the participants had neutralization of the omicron variant, and their ID50 geometric mean titers were 8.4 times lower than those against the D614G variant. However, after a booster dose of 50 μg of the vaccine, the ID50 geometric mean titers against the omicron variant increased 20.0 times, though they were still 2.9 times lower than those against the D614G variant. This is an interesting finding, and I'm looking forward to seeing more research on this topic.
 

Similar threads

  • · Replies 7 ·
Replies
7
Views
2K
  • · Replies 52 ·
2
Replies
52
Views
5K
  • · Replies 22 ·
Replies
22
Views
4K
  • · Replies 20 ·
Replies
20
Views
2K
  • · Replies 10 ·
Replies
10
Views
3K